Trials / Completed
CompletedNCT00525499
A Phase 2 Study of ASC-J9 Cream in Acne Vulgaris
A Phase 2, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled Dose-Ranging Clinical Study to Evaluate the Safety and Efficacy of ASC-J9 Cream Applied Twice Daily for 12 Weeks for the Treatment of Facial Acne Vulgaris
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 186 (actual)
- Sponsor
- AndroScience Corp · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate if topical ASC-J9 cream is effective in treating acne.
Detailed description
Subjects with acne were randomized to one of four treatment groups for twice daily topical dosing to the face for 12 weeks. Assessments of acne status were performed at Baseline, Weeks 2, 4, 8 and 12 and then 4 weeks after the last dose of study drug.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ASC-J9 cream | Topical application to the face twice daily for 12 weeks. |
| DRUG | placebo | vehicle control applied topically twice daily for 12 weeks |
Timeline
- Start date
- 2007-08-01
- Primary completion
- 2008-04-01
- Completion
- 2008-07-01
- First posted
- 2007-09-05
- Last updated
- 2011-11-23
- Results posted
- 2011-04-18
Locations
10 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00525499. Inclusion in this directory is not an endorsement.